ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,567.80
      (
      0.38%
      )
      US Tech 100
      15,528.80
      (
      -0.41%
      )
      Dow Jones
      35,950.89
      (
      1.47%
      )
      Brent Oil
      80.585
      (
      0.27%
      )
      Bitcoin
      38,143.77
      (
      1.14%
      )
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vertex Pharmaceuticals Inc (VRTX)

      7. Vertex Pharmaceuticals Inc (VRTX) News

      VRTX

      Vertex Pharmaceuticals (VRTX)

      Vertex Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VRTX
      DateTimeSourceHeadlineSymbolCompany
      11/29/20232:55PMDow Jones NewsVertex Pharmaceuticals' Kalydeco Gets Expanded Use Authorization from Health CanadaNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/29/20232:00PMPR Newswire (Canada)Santé Canada autorise la mise sur le marché de KALYDECO(MD) (ivacaftor) pour les enfants admissibles atteints de fibrose kystique âgés de 2 mois et plusNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/29/20231:59PMPR Newswire (Canada)Health Canada Grants Market Authorization for KALYDECO® (ivacaftor) for Eligible Children With Cystic Fibrosis Ages 2 Months and OlderNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/24/202310:06AMDow Jones NewsVertex Pharmaceuticals Gets Regulatory OK to Extend Use to More Patients in EuropeNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/24/20239:13AMBusiness WireVertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare MutationsNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/23/20239:54AMDow Jones NewsVertex Pharmaceuticals Cystic Fibrosis Treatment Approved for Young Children in EUNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/23/20239:05AMBusiness WireEuropean Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5NASDAQ:VRTXVertex Pharmaceuticals Inc
      11/21/20234:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/20/202311:54AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/17/20234:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/17/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/16/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/16/20231:45AMBusiness Wire Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta ThalassemiaNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/15/20234:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/15/20232:32PMDow Jones NewsVertex Pharmaceuticals Worst Performer in the S&P 500 and the Nasdaq 100 So Far Today -- Data TalkNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/15/202310:29AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/15/202310:26AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/14/202311:59AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/13/20233:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/08/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/07/20234:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRTXVertex Pharmaceuticals Inc
      11/07/20237:10AMIH Market NewsTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi, Alteryx, Intel, and more.NASDAQ:VRTXVertex Pharmaceuticals Inc
      11/06/20234:46PMDow Jones NewsVertex Pharmaceuticals 3Q Profit Rises on Continued Sales StrengthNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/06/20234:01PMBusiness WireVertex Reports Third Quarter 2023 Financial ResultsNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/06/202311:50AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/02/20234:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/02/20239:02AMBusiness WireVertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and ExpositionNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/02/20238:30AMBusiness WireVertex to Present Data Highlighting Long-Term Benefits of TRIKAFTA® at the North American Cystic Fibrosis ConferenceNASDAQ:VRTXVertex Pharmaceuticals Inc
      11/01/20236:29AMDow Jones NewsCrispr Therapeutics Shares Rally Premarket After Favorable FDA Panel MeetingNASDAQ:VRTXVertex Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VRTX